End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -3.35% | -4.04% | -8.18% |
05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Business Summary
Sales per Business
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Sales per region
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 03-07-31 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Zivit Harpaz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Sari Fishman
PRN | Corporate Officer/Principal | 52 | 03-12-31 |
William D. Kerns
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 00-12-31 |
Ilan Cohn
FOU | Founder | 68 | 94-09-10 |
Pnina Fishman
FOU | Founder | 74 | 94-09-10 |
Yaacov Goldman
BRD | Director/Board Member | 68 | 17-07-31 |
Guy Regev
BRD | Director/Board Member | 55 | 11-06-30 |
Yossi Bornstein
BRD | Director/Board Member | 66 | 21-08-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,497,128,493 | 1,496,706,120 ( 99.97 %) | 0 | 99.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- CANF Stock
- CANF Stock
- Company Can-Fite BioPharma Ltd.